Impact Factor 2.889 | CiteScore 3.1
More on impact ›
Dementia and Neurodegenerative Diseases aims to publish significant clinical and translational research findings on all aspects of neurodegenerative diseases.
*For the submission of a Case Report please, send the manuscript draft to neurology@frontiersin.org for pre-evaluation. Any Case Reports submitted without a previous enquiry might experience delays, as they will be sent for assessment prior to peer review.
Read moreThe rate of dementia due to neurodegenerative disease is rising sharply. More than 48 million people around the world are already affected, and this number is expected to double every 20 years, reaching 131 million in 2050. Caring for people with dementia and neurodegenerative diseases presents profound emotional, physical, and financial challenges to families and societies. While there are some palliative treatments for the symptoms of dementia, there are no known disease-modifying treatments for neurodegenerative diseases.
Dementia and Neurodegenerative Diseases is a specialty section of Frontiers in Neurology that aims to publish significant clinical and translational research findings on all aspects of neurodegenerative diseases. We welcome papers on cognitive, behavioral, and motor features of the neurodegenerative diseases, molecular insights into pathological prediction and disease mechanism, biomarkers for diagnosis and progression, potential therapeutics and clinical trials, or the relation between inflammation and neurodegeneration. Other important areas will be prevention and healthy aging and the model care of people with neurodegenerative diseases. Studies that create translational links between basic and clinical research will be particularly valued.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CrossRef, Embase, CLOCKSS
PMCID: NA
Dementia and Neurodegenerative Diseases welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Dementia and Neurodegenerative Diseases, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact neurology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact neurology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org